We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CEVEC and VPM Sign Exclusive License Agreement

News   Jan 04, 2013

 
CEVEC and VPM Sign Exclusive License Agreement
 
 
 

RELATED ARTICLES

Revealed: How Deadly Pneumococcus Suppresses Immune Defenses

News

Scientists have discovered a new and important function of a toxin produced by disease-causing bacteria that could have significant implications for future vaccine design.

READ MORE

Gonorrhea Research Accelerated by Reference Proteomics Databank

News

The first survey of its type generated a large-scale proteomics databank for researchers looking at antimicrobial resistance and gonococcal vaccines.

READ MORE

Turbocharging Antibodies with One Click

News

Scientists have developed a method to quickly enhance immune-system proteins for treatment research.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE